Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Nasal Decongestant as Bridge Therapy Combined With Intranasal Corticosteroids in Children With Persistent Allergic Rhinitis: A Randomized Controlled Trial

NCT07593898 is registered in ClinicalTrials.gov with Dr. Behcet Uz Children's Hospital as lead sponsor.

NCT NCT07593898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Nasal Decongestant as Bridge Therapy Combined With Intranasal Corticosteroids in Children With Persistent Allergic Rhinitis: A Randomized Controlled Trial
Lead sponsor
Dr. Behcet Uz Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 2, 2025
Completion date
January 16, 2026
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent allergic rhinitis